In fact, studies tell us its quite common
Binding to GHRH Receptors CJC-1295 binds to the actual Growth Hormone Releasing Hormone (GHRH) receptors on the anterior pituitary gland
Its clinically proven to be effective and safer than alternative peptide therapies
doi: 10.1016/j.mehy.2020.110412 34 CastejonA
Advantages of the liposomal form Better transport of the active substance to its destination - through the intestinal wall into the bloodstream and from there easy absorption directly into the cells Perfect bioavailability - availability of dietary supplements to the body Liposomal layer protects the active ingredient against damage in the digestive tract No aftertaste , long shelf life and purity (no additives) - all thanks to the bulk form What is it
Cuadrado and colleagues first showed that GSK-3 inhibits NRF2 activity, but the identification of sites in NRF2 that are phosphorylated by GSK-3 was achieved several years later using two-dimensional electrophoresis and mass spectrometry: GSK-3 phosphorylates a group of Ser residues at the level of DSGIS motif in the Neh6 domain of NRF2, and this event represents the signal for the recognition by the adapter protein -TrCP, that targets NRF2 for ubiquitination and proteasomal degradation in a KEAP1-independent manner [150, 151]